No more than 2% of all cancer types have missense mutations or deletions in the 3′-untranslated region (UTR) of ERK2 with moderate impact or probably deleterious meaning on the protein activity (available online: https://portal.gdc.cancer.gov/genes/ENSG00000100030). Here, MAPK1 is linked to cancer.